NOVOREX IBERICA, founded in 2020, operates in the pharmaceutical industry. The company recently secured a significant KRW11.50B Series A investment on 24 November 2023, attracting a consortium of notable investors including Company K Partners, KB Investments, UTC 2019 BioVentureFund, Woori Venture Partners, BNH Investment, Hana Ventures, AON Investment, Quad Asset Management, and Korea Technology Finance Corporation.
We care about your data, and we'd love to use cookies make your experience better.